ArticleTransplantation and cellular therapy2022

Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis.

Tania Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.